Volume 20 No 8 (2022)
 Download PDF
Recent Advances in Treatment of Bipolar Depression
Mohammad Gamal Sehlo, Hayam Mohamed El-Gohary, Samar Mohamed AbdElgayed, Merhan Ezzat Abdel Azeem Mohamed
Abstract
Bipolar Disorder (BD) and Major Depressive Disorder (MDD) are two of the most common mental illnesses causing disability in the world. Bipolar depression has been viewed as more endogenous than unipolar depression, based on significant evidence that mania is biologically driven. As a result of this difference in diagnostic categories, mood disorder research tends to focus on either bipolar disorder in general or unipolar depression in particular. Only a few studies have compared unipolar and bipolar depression. If the hypothesis of bipolar depression as distinct is correct, first, biological evidence should be more evident in bipolar depression than in unipolar depression. For example, bipolar depression may have a larger genetic contribution than unipolar depression. Second, one could expect bipolar and unipolar depression to progress in different ways. Third, psychosocial depression triggers should be less pronounced in bipolar depression than in unipolar depression. In conclusion, if unipolar and bipolar depression were distinct illnesses, we would expect biological, course, symptomatology, and psychosocial factors to differ. Pharmacological treatment is fundamental for successfully managing patients with BD. For acute episodes, the objective is symptom reduction, with the ultimate goal of full remission. For maintenance treatment, the goal is to prevent the recurrences of mood episodes. Medications used in the treatment of BD include mood stabilizers (e.g., lithium, valproate, lamotrigine, and carbamazepine), atypical antipsychotics, and conventional antidepressants
Keywords
Bipolar Disorder (BD) and Major Depressive Disorder (MDD) are two of the most common mental illnesses causing disability in the world. Bipolar depression has been viewed as more endogenous than unipolar depression, based on significant evidence that mania is biologically driven. As a result of this difference in diagnostic categories, mood disorder research tends to focus on either bipolar disorder in general or unipolar depression in particular. Only a few studies have compared unipolar and bipolar depression. If the hypothesis of bipolar depression as distinct is correct, first, biological evidence should be more evident in bipolar depression than in unipolar depression. For example, bipolar depression may have a larger genetic contribution than unipolar depression. Second, one could expect bipolar and unipolar depression to progress in different ways. Third, psychosocial depression triggers should be less pronounced in bipolar depression than in unipolar depression. In conclusion, if unipolar and
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.